EUVIMEDEUVIMED entdecken
Crossref

ORAI3 Modulates Oral Squamous Cell Carcinoma Metastasis Through the Ca 2+ /Calmodulin/Calcineurin/ ETV4 Signaling Pathway

Shu Chen iD, Heqing Zhang, Bing Shen iD, Shuangyan Guo, Huiying Chen, Xinyuan Jin, Lesha Zhang, Jizheng Guo, Haowei Xue

The FASEB Journal · 2025

DOI: 10.1096/fj.202501276r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Shu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Calcineurin, Calmodulin, Calcium Channels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Health Research Project, Anhui province, Macau University of Science and Technology Foundation (MUST Foundation), The Science and Technology Development Fund, Macau SAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) significantly impairs a person's physical and psychological health despite active treatment efforts. Thus, it is important to investigate the pathogenesis of OSCC to discover new therapeutic targets for clinical treatments. ORAI3 is a store‐operated calcium (Ca 2+ ) channel that has been associated with several cancers, including breast, prostate, and pancreas. Although the ORAI3 channel is recognized for its oncogenic potential, its pathological functions in OSCC are not well understood, especially concerning its involvement in cancer progression. In this study, we found that ORAI3 was upregulated in OSCC clinical samples and cell lines. When the expression of ORAI3 was knocked down in vitro in OSCC cells, store‐operated calcium entry–mediated Ca 2+ influx into the cells was reduced. Importantly, the proliferation, migration, and invasive capabilities of these OSCC cells were also markedly decreased. Application of calmodulin or calcineurin inhibitors (W‐7 or CsA, respectively) further suppressed these cell functions. Transcriptomic analysis revealed that ORAI3 knockdown led to downregulation of ETV4, a member of the ETS transcription factor family that is involved in cell differentiation, proliferation, and apoptosis and has been shown to be upregulated in some types of cancer. Here, overexpression of ETV4 rescued the suppressive effects on the proliferation, migration, and invasive capabilities of OSCC cells caused by ORAI3 knockdown. In addition, treatment with the calcineurin inhibitor CsA markedly reduced ETV4 expression levels in OSCC cells. Taken together, these results indicated that ORAI3 drives cancer progression by activating the Ca 2+ /calmodulin/calcineurin/ETV4 signaling pathway. Overall, these findings suggest that ORAI3/ETV4 may be a therapeutic target for the treatment of OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCalcineurinCalmodulinCalcium ChannelsProto-Oncogene Proteins c-etsCalciumProto-Oncogene ProteinsCarcinoma, Squamous CellHumansCell Line, TumorSignal TransductionCell ProliferationCell MovementGene Expression Regulation, NeoplasticMaleNeoplasm MetastasisCalcium Signaling

Stichwörter der Autor:innen

ETV4ORAI3OSCCcalcineurincalmodulinstore‐operated Ca2+ entry

Substanzen

Orai3 protein, humanCalcineurinCalmodulinCalcium ChannelsProto-Oncogene Proteins c-etsCalciumETV4 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, China.
  • School of Basic Medicine Sciences, Anhui Medical University, Hefei, China.

ORCID-Profile: Shu Chen, Bing Shen

Förderung

  • Health Research Project, Anhui province
  • Macau University of Science and Technology Foundation (MUST Foundation)
  • The Science and Technology Development Fund, Macau SAR

Zitieren

APA

Chen, S., Zhang, H., Shen, B., Guo, S., Chen, H., Jin, X., Zhang, L., Guo, J., & Xue, H. (2025). ORAI3 Modulates Oral Squamous Cell Carcinoma Metastasis Through the Ca 2+ /Calmodulin/Calcineurin/ ETV4 Signaling Pathway. The FASEB Journal. https://doi.org/10.1096/fj.202501276r

Vancouver

Chen S, Zhang H, Shen B, Guo S, Chen H, Jin X, et al. ORAI3 Modulates Oral Squamous Cell Carcinoma Metastasis Through the Ca 2+ /Calmodulin/Calcineurin/ ETV4 Signaling Pathway. The FASEB Journal. 2025. doi:10.1096/fj.202501276r

BibTeX
@article{Chen2025,
  author = {Chen, Shu and Zhang, Heqing and Shen, Bing and Guo, Shuangyan and Chen, Huiying and Jin, Xinyuan and Zhang, Lesha and Guo, Jizheng and Xue, Haowei},
  title = {ORAI3 Modulates Oral Squamous Cell Carcinoma Metastasis Through the Ca 2+ /Calmodulin/Calcineurin/ ETV4 Signaling Pathway},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501276r}
}
Kostenlos starten →